This inventor holds 3 USPTO granted patents. Top assignees: Massachusetts Institute of Technology, The General Hospital Corporation, Other. Active years: 1998-2004.
Company Filing History:
2 out of 8,573 
2 out of 3,068 
1 out of 834,350 Years Active: 1998-2004
Title: The Innovations of Daniel R. Rosen
Introduction
Daniel R. Rosen is a notable inventor based in Dedham, MA (US). He has made significant contributions to the field of neurodegenerative diseases, particularly in relation to Amyotrophic Lateral Sclerosis (ALS). With a total of 3 patents, his work has advanced the understanding and treatment of this debilitating condition.
Latest Patents
Rosen's latest patents include groundbreaking research on mice having a mutant SOD-1-encoding transgene. This patent discloses the family of genes responsible for neurodegenerative diseases, particularly ALS. Additionally, he has developed methods and compounds for the diagnosis, prevention, and therapy of the disease, further contributing to the medical community's efforts to combat ALS.
Career Highlights
Throughout his career, Daniel R. Rosen has worked with prestigious institutions such as The General Hospital Corporation and the Massachusetts Institute of Technology. His research has not only advanced scientific knowledge but has also paved the way for potential therapeutic interventions for ALS.
Collaborations
Rosen has collaborated with esteemed colleagues, including H. Robert Horvitz and Robert A. Brown. These partnerships have enriched his research and expanded the impact of his innovations in the field of neurodegenerative diseases.
Conclusion
Daniel R. Rosen's contributions to the understanding and treatment of neurodegenerative diseases are invaluable. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.